Robotic Surgery for Head & Neck Cancer

TORS For Head and Neck Cancer

Head and neck cancer represents a broad group of dangerous cancers that arise from the nasal cavity and sinuses, oral cavity (mouth), pharynx (throat), larynx (voicebox), salivary glands, thyroid or skin.
Each year experts at OHSU treat nearly 400 patients with head and neck cancer from Oregon, Southwest Washington, Alaska, Idaho and beyond.

TransOral Robotic Surgery

OHSU head and neck surgeons pioneered TORS, a new minimally invasive surgical approach. Read more

The US Food and Drug Administration (FDA) have approved TORS for the treatment of benign and malignant tumors of the oral cavity and throat and many head and neck cancer patients can now be treated with this procedure. Read more

TransOral robotic surgery is most commonly used to treat:

  • Tonsil cancers
  • Cancers on the base of the tongue
  • There is also active research exploring TORS as a treatment for obstructive sleep apnea.

Benefits of TORS include:

  • Smaller incisions, sometimes no external incisions
  • Less invasive
  • Less pain
  • Fewer complications
  • Shorter hospital stay
  • Faster recovery and earlier return to normal activities